Physician profile
Lori Quinn-Tate
NPI 1588666762
$14,112.44
in general payments reported to CMS, 2019-2025
45 companies · $3,596 in 2025
The $3,596 reported for 2025 was more than what 98% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $928 · 2022: $2,291 · 2023: $3,336 · 2024: $3,961 · 2025: $3,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,644 · Travel and Lodging: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,644.08 |
| Travel and Lodging | $1,248.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,517.46 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Boston Scientific Corporation | $1,198.13 | 2022-2025 | Emblem Mri S-Icd, Bodyguardian, Watchman Flx |
| Medtronic, INC. | $1,129.43 | 2021-2025 | Linq II, Micra, Selectsecure |
| Abbvie INC. | $1,094.37 | 2021-2025 | |
| Novo Nordisk INC | $734.29 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $514.70 | 2022-2025 | Caplyta |
| Amgen INC. | $503.59 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.02 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $412.70 | 2022-2025 | Verquvo, Capvaxive |
| Alexion Pharmaceuticals, INC. | $368.89 | 2023-2025 | Ultomiris |
| Qol Medical, LLC | $348.04 | 2022-2024 | Sucraid |
| Neurelis, INC. | $332.53 | 2022-2024 | Valtoco |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $326.55 | 2022-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $312.41 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $297.41 | 2022-2025 | Camzyos, Eliquis |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $294.29 | 2022 | |
| Gilead Sciences, INC. | $288.83 | 2021-2024 | Epclusa |
| Esperion Therapeutics, INC. | $266.38 | 2022-2025 | Nexletol, Nexlizet |
| Janssen Scientific Affairs, LLC | $259.62 | 2023-2024 | Xarelto |
| Dexcom, INC. | $255.43 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Actelion Pharmaceuticals US, INC. | $243.39 | 2024-2025 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $230.18 | 2023-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $220.58 | 2021-2022 | |
| Lilly USA, LLC | $217.87 | 2022-2024 | Zepbound, Trulicity, Mounjaro |
| Phathom Pharmaceuticals, INC. | $214.99 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $214.94 | 2022-2023 | |
| Atricure, INC. | $198.05 | 2024 | |
| Inspire Medical Systems, INC. | $185.32 | 2024-2025 | Inspire |
| Abbott Laboratories | $166.06 | 2023 | Freestyle Libre 3, Cardiomems |
| Edwards Lifesciences Corporation | $141.55 | 2025 | |
| Intercept Pharmaceuticals, INC. | $125.00 | 2022 | |
| Astellas Pharma US INC | $123.90 | 2023 | Veozah |
| Teva Pharmaceuticals USA, INC. | $106.82 | 2024 | Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $100.00 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $100.00 | 2021 | |
| Idorsia Pharmaceuticals US INC | $100.00 | 2023 | Quviviq |
| Exact Sciences Corporation | $97.31 | 2025 | The Cologuard Plus Collection Kit |
| Genzyme Corporation | $96.63 | 2024 | |
| Ardelyx, INC. | $88.83 | 2025 | Ibsrela |
| Amarin Pharma, INC. | $84.07 | 2021 | |
| Kestra Medical Technology Services, INC. | $69.86 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.43 | 2024-2025 | Lifevest |
| Scpharmaceuticals INC. | $18.43 | 2023 | |
| Inari Medical, INC. | $18.09 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $17.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Quinn-Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.